- Home
- PRLD vs EIC Comparison
PRLD vs EIC Comparison
Compare PRLD & EIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PRLD | EIC |
|---|---|---|
| Founded | 2016 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 218.0M | 228.8M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | PRLD | EIC |
|---|---|---|
| Price | $4.52 | $9.99 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | $5.67 | ★ $12.63 |
| AVG Volume (30 Days) | ★ 415.0K | 126.0K |
| Earning Date | 05-13-2026 | 05-27-2026 |
| Dividend Yield | N/A | ★ 13.21% |
| EPS Growth | ★ 23.21 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $12,140,000.00 | N/A |
| Revenue This Year | $320.10 | N/A |
| Revenue Next Year | $100.00 | N/A |
| P/E Ratio | ★ N/A | $9.08 |
| Revenue Growth | ★ 73.43 | N/A |
| 52 Week Low | $0.73 | $9.17 |
| 52 Week High | $5.54 | $14.80 |
Technical Indicators
Market Signals| Indicator | PRLD | EIC |
|---|---|---|
| Relative Strength Index (RSI) | 57.45 | 62.02 |
| Support Level | $1.09 | $9.78 |
| Resistance Level | $5.54 | $10.15 |
| Average True Range (ATR) | 0.65 | 0.19 |
| MACD | -0.03 | 0.05 |
| Stochastic Oscillator | 38.30 | 69.28 |
Price Performance
Historical ComparisonAbout PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a precision oncology company developing medicines in areas of high unmet need for cancer patients. Its pipeline features selective KAT6A degraders and mutant selective JAK2V617F JH2 inhibitors, new approaches to clinically validated targets with transformative potential for patients. The company is also leveraging its expertise in targeted protein degradation to discover and develop next-generation degrader antibody conjugates (DACs) with novel payloads.
About EIC Eagle Point Income Company Inc.
Eagle Point Income Co Inc is a closed-end management investment company. Its primary investment objective is to generate high current income, with a secondary objective to generate capital appreciation. The Company seeks to achieve its investment objectives by investing in junior debt tranches of collateralized loan obligations, or "CLOs," that are collateralized by a portfolio consisting of below-investment grade U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors.